HF
AGIO icon

HRT Financial’s Agios Pharmaceuticals AGIO Stock Holding History

HRT Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96M Sell
160,759
-34,673
-18% -$1.05M 0.01% 1059
2026
Q1 		$6.61M Buy
195,432
+48,963
+33% +$1.39M 0.02% 837
2025
Q4 		$3.99M Buy
+146,469
New +$5.14M 0.01% 888
2025
Q1 		– Sell
-23,229
Closed -$763K – 2463
2024
Q4 		$763K Sell
23,229
-5,525
-19% -$260K ﹤0.01% 1226
2024
Q3 		$1.28M Buy
+28,754
New +$1.31M 0.01% 1102
2023
Q2 		– Sell
-9,817
Closed -$225K – 2386
2023
Q1 		$225K Sell
9,817
-3,330
-25% -$88.5K ﹤0.01% 1875
2022
Q4 		$369K Buy
+13,147
New +$371K 0.01% 1613
2022
Q1 		– Sell
-38,805
Closed -$1.27M – 3021
2021
Q4 		$1.27M Buy
+38,805
New +$1.56M 0.01% 930
2021
Q2 		– Sell
-53,668
Closed -$2.77M – 2786
2021
Q1 		$2.77M Buy
+53,668
New +$2.66M 0.03% 466

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

HRT Financial's AGIO Position: Q2 2026 in Review

HRT Financial reduced its Agios Pharmaceuticals (AGIO) stake by 18% in Q2 2026, selling an estimated $1.05M and leaving 160,759 shares worth $5.96M. The position accounts for 0.01% of the portfolio, ranked #1059.

HRT Financial first reported a position in AGIO in Q1 2021 and has held it in 9 quarters since. The position peaked at $6.61M in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • HRT Financial held 160,759 shares of Agios Pharmaceuticals worth $5.96M as of Q2 2026.
  • HRT Financial sold 34,673 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.05M.
  • Agios Pharmaceuticals made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1059 holding.
  • HRT Financial first reported a position in Agios Pharmaceuticals in Q1 2021 and has held it in 9 quarters since.
  • HRT Financial's Agios Pharmaceuticals position peaked at $6.61M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.